• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于长骨修复的与大孔生物陶瓷相关的干细胞:一项试点临床研究的6至7年结果

Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study.

作者信息

Marcacci Maurilio, Kon Elizaveta, Moukhachev Vladimir, Lavroukov Andrei, Kutepov Sergej, Quarto Rodolfo, Mastrogiacomo Maddalena, Cancedda Ranieri

机构信息

Laboratorio di Biomeccanica, Istituti Ortopedici Rizzoli, Bologna, Italy.

出版信息

Tissue Eng. 2007 May;13(5):947-55. doi: 10.1089/ten.2006.0271.

DOI:10.1089/ten.2006.0271
PMID:17484701
Abstract

Extensive bone loss is still a major problem in orthopedics. A number of different therapeutic approaches have been developed and proposed, but so far none have proven to be fully satisfactory. We used a new tissue engineering approach to treat four patients with large bone diaphysis defects and poor therapeutic alternatives. To obtain implantable three-dimensional (3D) living constructs, cells isolated from the patients' bone marrow stroma were expanded in culture and seeded onto porous hydroxyapatite (HA) ceramic scaffolds designed to match the bone deficit in terms of size and shape. During the surgical session, an Ilizarov apparatus or a monoaxial external fixator was positioned on the patient's affected limb and the ceramic cylinder seeded with cells was placed in the bone defect. Patients were evaluated at different postsurgery time intervals by conventional radiographs and computed tomography (CT) scans. In one patient, an angiographic evaluation was performed at 6.5 years follow-up. In this study we analyze the long-term outcome of these patients following therapy. No major complications occurred in the early or late postoperative periods, nor were major complaints reported by the patients. No signs of pain, swelling, or infection were observed at the implantation site. Complete fusion between the implant and the host bone occurred 5 to 7 months after surgery. In all patients at the last follow-up (6 to 7 years postsurgery in patients 1 to 3), a good integration of the implants was maintained. No late fractures in the implant zone were observed. The present study shows the long-term durability of bone regeneration achieved by a bone engineering approach. We consider the obtained results very promising and propose the use of culture-expanded osteoprogenitor cells in conjunction with porous bioceramics as a real and significant improvement in the repair of critical-sized long bone defects.

摘要

广泛的骨质流失仍是骨科领域的一个主要问题。人们已经开发并提出了多种不同的治疗方法,但迄今为止,尚无一种方法被证明是完全令人满意的。我们采用一种新的组织工程方法治疗了4例患有大段骨干缺损且治疗选择有限的患者。为了获得可植入的三维(3D)活体构建物,从患者骨髓基质中分离出的细胞在培养中进行扩增,然后接种到设计成在尺寸和形状上与骨缺损相匹配的多孔羟基磷灰石(HA)陶瓷支架上。在手术过程中,将伊利扎罗夫器械或单轴外固定器放置在患者的患肢上,并将接种了细胞的陶瓷圆柱体置于骨缺损处。通过传统X线片和计算机断层扫描(CT)对患者在不同的术后时间间隔进行评估。在1例患者中,在随访6.5年时进行了血管造影评估。在本研究中,我们分析了这些患者治疗后的长期结果。术后早期或晚期均未发生重大并发症,患者也未报告重大不适。在植入部位未观察到疼痛、肿胀或感染迹象。术后5至7个月,植入物与宿主骨完全融合。在最后一次随访时(患者1至3术后6至7年),所有患者的植入物均保持良好的整合状态。在植入区域未观察到晚期骨折。本研究显示了通过骨工程方法实现的骨再生的长期耐久性。我们认为所获得的结果非常有前景,并建议将培养扩增的骨祖细胞与多孔生物陶瓷联合使用,作为对临界尺寸长骨缺损修复的一项切实且重大的改进。

相似文献

1
Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study.用于长骨修复的与大孔生物陶瓷相关的干细胞:一项试点临床研究的6至7年结果
Tissue Eng. 2007 May;13(5):947-55. doi: 10.1089/ten.2006.0271.
2
Bone marrow stromal cells and their use in regenerating bone.骨髓基质细胞及其在骨再生中的应用。
Novartis Found Symp. 2003;249:133-43; discussion 143-7, 170-4, 239-41.
3
Tissue engineering of bone: search for a better scaffold.骨组织工程:寻找更好的支架材料
Orthod Craniofac Res. 2005 Nov;8(4):277-84. doi: 10.1111/j.1601-6343.2005.00350.x.
4
In vivo evaluation of a bioactive scaffold for bone tissue engineering.用于骨组织工程的生物活性支架的体内评估
J Biomed Mater Res. 2002 Oct;62(1):1-13. doi: 10.1002/jbm.10157.
5
Osteochondral repair using a scaffold-free tissue-engineered construct derived from synovial mesenchymal stem cells and a hydroxyapatite-based artificial bone.使用源自滑膜间充质干细胞和羟基磷灰石基人工骨的无支架组织工程构建体进行骨软骨修复。
Tissue Eng Part A. 2014 Sep;20(17-18):2291-304. doi: 10.1089/ten.tea.2013.0414. Epub 2014 Mar 21.
6
Rat bone marrow stromal cells-seeded porous gelatin/tricalcium phosphate/oligomeric proanthocyanidins composite scaffold for bone repair.载骨髓基质细胞的多孔明胶/三钙磷酸盐/低聚原花青素复合支架修复骨缺损
J Tissue Eng Regen Med. 2013 Sep;7(9):708-19. doi: 10.1002/term.1461. Epub 2012 Mar 6.
7
[Scintigraphic detection of osteoblast activity after implantation of BAS-0 bioactive glass-ceramic material into long bone defects].[将BAS-0生物活性玻璃陶瓷材料植入长骨缺损后成骨细胞活性的闪烁扫描检测]
Acta Chir Orthop Traumatol Cech. 2006 Jun;73(3):176-82.
8
Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats.有活力的成骨细胞对于山羊组织工程异位骨形成是必不可少的。
Tissue Eng. 2003 Apr;9(2):327-36. doi: 10.1089/107632703764664792.
9
Tissue regeneration and repair of goat segmental femur defect with bioactive triphasic ceramic-coated hydroxyapatite scaffold.生物活性三相陶瓷涂层羟基磷灰石支架修复山羊节段性股骨缺损的组织再生和修复。
J Biomed Mater Res A. 2009 Dec;91(3):855-65. doi: 10.1002/jbm.a.32239.
10
Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption.利用骨髓基质细胞和硅稳定磷酸三钙生物陶瓷构建骨组织:骨形成与支架吸收之间耦合的证据
Biomaterials. 2007 Mar;28(7):1376-84. doi: 10.1016/j.biomaterials.2006.10.001. Epub 2006 Nov 28.

引用本文的文献

1
Self-assembled hybrid hydrogel microspheres create a bone marrow-mimicking niche for bone regeneration.自组装混合水凝胶微球为骨再生创造了一个模拟骨髓的微环境。
Bioact Mater. 2025 Aug 17;54:179-200. doi: 10.1016/j.bioactmat.2025.08.003. eCollection 2025 Dec.
2
Lost in translation: the lack of agreement between surgeons and scientists regarding biomaterials research and innovation for treating bone defects.迷失在翻译中:外科医生和科学家在生物材料研究和治疗骨缺损创新方面缺乏共识。
BMC Med. 2024 Nov 6;22(1):517. doi: 10.1186/s12916-024-03734-z.
3
Revolutionizing bone defect healing: the power of mesenchymal stem cells as seeds.
革新骨缺损愈合:间充质干细胞作为种子的力量。
Front Bioeng Biotechnol. 2024 Oct 21;12:1421674. doi: 10.3389/fbioe.2024.1421674. eCollection 2024.
4
Fourteen-Year Follow-Up of a Patient With a Hydroxyapatite Ceramic Matrix Reconstruction of and a Bone Graft for a Critical-Size Cortical Bone Defect: A Case Report.一名采用羟基磷灰石陶瓷基质重建并植入骨移植治疗临界尺寸皮质骨缺损患者的14年随访:病例报告
Cureus. 2024 Jul 5;16(7):e63901. doi: 10.7759/cureus.63901. eCollection 2024 Jul.
5
Towards Stem Cell Therapy for Critical-Sized Segmental Bone Defects: Current Trends and Challenges on the Path to Clinical Translation.走向用于大段临界尺寸骨缺损的干细胞治疗:临床转化之路的当前趋势与挑战
J Funct Biomater. 2024 May 27;15(6):145. doi: 10.3390/jfb15060145.
6
Cellular therapies for bone repair: current insights.细胞疗法在骨修复中的应用:最新研究进展。
J Orthop Traumatol. 2024 May 24;25(1):28. doi: 10.1186/s10195-024-00768-0.
7
Safety of a Porous Hydroxyapatite Bone Substitute in Orthopedics and Traumatology: A Multi-Centric Clinical Study.一种多孔羟基磷灰石骨替代物在骨科与创伤学中的安全性:一项多中心临床研究。
J Funct Morphol Kinesiol. 2024 Apr 11;9(2):71. doi: 10.3390/jfmk9020071.
8
3D printing technology and its combination with nanotechnology in bone tissue engineering.3D打印技术及其在骨组织工程中与纳米技术的结合。
Biomed Eng Lett. 2024 Jan 30;14(3):451-464. doi: 10.1007/s13534-024-00350-x. eCollection 2024 May.
9
Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients.间充质干/基质细胞:骨肉瘤患者肿瘤切除后的免疫调节和骨再生潜力
Bioengineering (Basel). 2023 Oct 13;10(10):1187. doi: 10.3390/bioengineering10101187.
10
Convergence of scaffold-guided bone regeneration principles and microvascular tissue transfer surgery.支架引导骨再生原则与微血管组织转移手术的融合。
Sci Adv. 2023 May 5;9(18):eadd6071. doi: 10.1126/sciadv.add6071.